Delivery Order SPE2DB25D3002-SPE2DB25FLRCT
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $3,987.58 to AmerisourceBergen Drug Corp for Zepbound 2.5 mg/0.5 ml pens on August 12, 2025, with completion targeted for August 13, 2025. This firm fixed-price delivery order, issued without a set-aside designation, represents a competitive award to the prime contractor for pharmaceutical supply to federal medical procurement needs. The performance location is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order valued at $3,134.75 to AmerisourceBergen Drug Corp for the supply of Zepbound 2.5 mg/0.5 mL pen injections (0.5 mL units). This competitively awarded, firm fixed-price delivery order was issued on August 4, 2025, with an ultimate completion date of August 5, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The contract represents a continuation of the federal healthcare supply...
- The Defense Logistics Agency awarded a delivery order valued at $3,050.40 to AmerisourceBergen Drug Corp on August 1, 2025, for the supply of Zepbound 7.5 mg/0.5 mL pens. This is a firm fixed price, competitively awarded delivery order with no set-aside designation and an ultimate completion date of August 4, 2025. The order will be fulfilled from AmerisourceBergen's location in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters. This delivery order represents a...
- The Defense Logistics Agency awarded a delivery order valued at $13,980.14 to AmerisourceBergen Drug Corp for the supply of Zepbound 5 mg/0.5 mL pens on July 30, 2025. This firm fixed-price delivery order, with an ultimate completion date of July 31, 2025, represents a competitively awarded non-set-aside contract for pharmaceutical supplies to support federal medical procurement needs. The product will be performed from AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a $13,474.62 delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of Zepbound 2.5 mg/0.5 mL pens. This firm fixed price delivery order, which is not set-aside designated, will be performed at the contractor's facility in Conshohocken, Pennsylvania, with an ultimate completion date of August 5, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical federal medical...
- The Defense Logistics Agency awarded a $5,476.25 delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Zepbound 7.5 mg/0.5 mL pens. This competitively awarded, firm fixed-price delivery order is scheduled for completion by July 30, 2025, with performance at AmerisourceBergen's Conshohocken, Pennsylvania location. The contract carries no set-aside designation, reflecting the vendor's demonstrated capability to compete in open federal procurement processes for...
- The Defense Logistics Agency awarded a $2,465.15 delivery order to AmerisourceBergen Drug Corp for Zepbound 5 mg/0.5 mL pens on July 22, 2025, with completion scheduled for July 23, 2025. This firm fixed price, non-set-aside contract represents a small-value pharmaceutical delivery to support federal medical procurement needs. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for military and veteran healthcare systems through its extensive...
- The Defense Logistics Agency awarded a delivery order valued at $5,381.98 to AmerisourceBergen Drug Corp for the supply of Zepbound 2.5 mg/0.5 mL pens on August 4, 2025, with an ultimate completion date of August 5, 2025. This is a firm fixed price delivery order with no set-aside designation, awarded competitively under the company's existing contract vehicle. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company...
- The Defense Logistics Agency awarded a delivery order valued at $3,768.42 to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of Zepbound 7.5 mg/0.5 ml pens. This firm fixed price contract, which is not set-aside and is scheduled for completion by July 28, 2025, represents a competitive award to the pharmaceutical distributor for medical supplies supporting federal healthcare operations. The delivery will be performed at AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a delivery order valued at $22,965.91 to AmerisourceBergen Drug Corp for the supply of Zepbound 7.5 mg/0.5 mL pens on July 30, 2025, with completion targeted for July 31, 2025. This competitively awarded, firm fixed-price delivery order is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award carries no set-aside designation, reflecting the company's competitive standing in federal pharmaceutical...
- SPE2DB25D3002Indefinite Delivery Contract
- SPE2DB25D3002-SPE2DB25FLRCTDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $3,897 to AmerisourceBergen Drug Corp for Zepbound 2.5 mg/0.5 ml pens on July 25, 2025, with completion scheduled for July 28, 2025. This firm fixed-price delivery order represents a non-set-aside, competitively awarded contract fulfilling pharmaceutical supply requirements for federal medical procurement. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.999 billion prime contract vehicle extending through December 2026 that provides comprehensive global pharmaceutical support to military healthcare programs. As a major pharmaceutical distributor, AmerisourceBergen maintains an extensive portfolio of federal medical supply contracts with the Defense Logistics Agency and Medical Supply Chain, distributing brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains to support Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.9k | 7/25/25 |